Published October 2017 | Version v1
Journal article

Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI?

  • 1. Glenfield Hospital, University Hospitals of Leicester, Groby Road, Leicester LE3 9QP (United Kingdom)
  • 2. Heartlands Hospitals, Heart of England NHS foundation Trust, Bordesley Green E, Birmingham B9 5SS (United Kingdom)
  • 3. Kettering General Hospital, Treatment Centre, Rothwell Rd, Kettering NN16 8UZ (United Kingdom)
  • 4. University Hospital of North Midlands, Newcastle Rd, Stoke-on-Trent, ST4 6QG (United Kingdom)
  • 5. Glenfield Hospital, University Hospitals of Leicester, Groby Road Leicester LE3 9QP (United Kingdom)
  • 6. Breast Unit, King's Mill Hospital, Sherwood Forest Hospitals, Sutton-in-Ashfield, Nottinghamshire, NG17 4JL (United Kingdom)

Description

Introduction: Preoperative assessment of pure Ductal Carcinoma Insitu (DCIS) is essential in the surgical planning. The role of Magnetic resonance imaging (MRI) has long been debated. The impact of MRI on the management of High Grade (HG) DCIS was assessed, whether it accurately captures the true size of this entity in comparison to conventional imaging, and, if MRI use would reduce the number of re-excision surgery. Method: Ninety-one consecutive patients with HG DCIS, who were identified from a prospectively collected data at Kettering General Hospital between April 2011 and December 2015. All patients had preoperative MRI scan in addition to the standard breast imaging. This was compared to a control group of consecutive patients (n = 52) which was obtained from a period just before 2011. Impact on surgical planning and number of surgeries for each patient was compared. The size of HG DCIS estimated by MRI was compared to the final histological size. Secondary outcomes included change of initial surgical plan and detection of occult contralateral breast cancer. Results: MRI group had 91 patients with median age of 63. Seventy percent of which presented through the screening program. The overall sensitivity of MRI to detect HG DCIS was 77% (70/91) with a false negative rate FNR of 23% (21/91). Therefore, 70 patients only were included in the data analysis. The control group included 52 screening patients with comparable baseline characteristics. Re-excision (or completion mastectomy) rates were higher in the control group 26% compared to 8% in the MRI group (P-value 0.012). MRI use correctly converted the initial plan of breast conservation to mastectomy in 9 patients (13%). Five patients had additional ipsilateral malignant features (7%).Occult contra lateral disease, was diagnosed in 2 patients (3%). Conclusion: This study suggests that MRI could be an important tool in reducing the re-excision rates in the surgical management of HG DCIS. Although still controversial, selective MRI imaging can be useful in the preoperative diagnosis and evaluation of HG DCIS. Case by case discussion at MDT is crucial. Wider adaptation of MRI when indicated in the assessment of breast lesions with proper correlation to histology postoperatively is a key in improving our MRI interpretation skills, helping us to exploit the full scope of this useful tool.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ejrad.2017.08.027

Additional details

Identifiers

DOI
10.1016/j.ejrad.2017.08.027;
PII
S0720-048X(17)30347-9;

Publishing Information

Journal Title
European Journal of Radiology
Journal Volume
95
Journal Page Range
p. 271-277
ISSN
0720-048X
CODEN
EJRADR

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49088633
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
MAMMARY GLANDS; NEOPLASMS; NMR IMAGING; PATIENTS; RADIOSENSITIVITY; SURGERY
Descriptors DEC
BODY; DIAGNOSTIC TECHNIQUES; DISEASES; GLANDS; MEDICINE; ORGANS; SENSITIVITY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.